Patents by Inventor Gakuzo Tamura

Gakuzo Tamura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6605639
    Abstract: It has been newly found out that ascochlorin, which is a publicly known fat-soluble antibiotic, and its homologues serve as a ligand of retinoid X receptor and react in vivo with the amino group of serum protein to form Schiff bases without showing any side effect of retinoid. Ascochlorin and its homologues are usable in treating and/or preventing a disease or condition which can be relieved by the retinoid X receptor ligand-dependent gene transcriptional regulation (for example, diseases caused by the expression of insulin resistance, hypertension, cerebrovascular diseases, rheumatoid arthritis, autoimmune disease, Ca metabolic disorder, complication of diabetes, arteriosclerosis, etc.). Moreover, they can inhibit denaturation and/or necrosis of pancreatic Langerhans islet &bgr;-cells and, therefore, are usable in making these cells to sustain the insulin productivity.
    Type: Grant
    Filed: June 14, 2001
    Date of Patent: August 12, 2003
    Assignee: Nuclear Receptor Research, Ltd.
    Inventors: Gakuzo Tamura, Kunio Ando, Junji Magae, Takafumi Uchida
  • Patent number: 4849351
    Abstract: Vector plasmids are constructed to provide sites for insertion of a structural gene in phase with three reading frames downstream from the promoter of alkaline phosphatase gene of Escherichia coli.
    Type: Grant
    Filed: December 8, 1986
    Date of Patent: July 18, 1989
    Assignee: Gakuzo Tamura
    Inventors: Gakuzo Tamura, Koji Yoda, Yasuhiro Kikuchi, Makari Yamasaki
  • Patent number: 4542143
    Abstract: Ascochlorin derivatives of the formula: ##STR1## wherein R is a hydroxyl group, a lower alkoxy group, a pyridyl group, an amino group, a dialkylamino group, a phenoxyalkyl group which may have a substituent in the nucleus, or a phenyl group which may have a substituent in the nucleus; and n is an integer of 0 to 5, a process for preparing the same and a pharmaceutical composition containing the same are disclosed.The derivatives are useful to treat diabetes, improve lipid metabolism and control tumors.
    Type: Grant
    Filed: May 3, 1984
    Date of Patent: September 17, 1985
    Assignee: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Tomoyoshi Hosokawa, Ikutoshi Matsuura, Hidenori Takahashi, Kunio Ando, Gakuzo Tamura
  • Patent number: 4500544
    Abstract: Ascochlorin derivatives of the formula: ##STR1## wherein R is a hydroxyl group, a lower alkoxy group, a pyridyl group, an amino group, a dialkylamino group, a phenoxyalkyl group which may have a substituent in the nucleus, or a phenyl group which may have a substituent in the nucleus; and n is an integer of 0 to 5, a process for preparing the same and a pharmaceutical composition containing the same are disclosed.The derivatives are useful to treat diabetes, improve lipid metabolism and control tumors.
    Type: Grant
    Filed: August 27, 1982
    Date of Patent: February 19, 1985
    Assignee: Chugai Seiyaku Kabushiki Kaisha
    Inventors: Tomoyoshi Hosokawa, Ikutoshi Matsuura, Hidenori Takahashi, Kunio Ando, Gakuzo Tamura
  • Patent number: 4221908
    Abstract: The antibacterial compound S551-II (Reductiomycin) is produced by culturing a microorganism belonging to the genus Streptomyces.S551-II-A is prepared by sublimation of the compound S551-II.
    Type: Grant
    Filed: April 16, 1979
    Date of Patent: September 9, 1980
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Gakuzo Tamura, Kenichi Shimizu
  • Patent number: 4202968
    Abstract: New tunicamine derivatives are provided which exhibit antiviral activity against some virus, particularly Newcastle disease virus, and inhibitory activity against coccidiosis and which are also of particular value as intermediates for the preparation of a variety of useful antibacterial, antitumor and antiviral compounds. They have a structure of the formula: ##STR1## wherein R represents hydrogen or a fatty acid residue of the formula (CH.sub.3).sub.2 CH(CH.sub.2).sub.n CH.dbd.CHCO-- where n represents an integer of 8 to 11 inclusive. They are prepared either by fermentation methods or by acid hydrolysis of the known antibiotic tunicamycin.
    Type: Grant
    Filed: June 29, 1978
    Date of Patent: May 13, 1980
    Assignee: Meiji Seika Kaisha, Ltd.
    Inventors: Gakuzo Tamura, Akira Takatsuki
  • Patent number: 4180436
    Abstract: The antibacterial compound S551-II (Reductiomycin) is produced by culturing a microorganism belonging to the genus Streptomyces.S551-II-A is prepared by sublimation of the compound S551-II.
    Type: Grant
    Filed: February 17, 1978
    Date of Patent: December 25, 1979
    Assignee: Kyowa Hakko Kogyo Co., Ltd.
    Inventors: Gakuzo Tamura, Kenichi Shimizu